Spirk, David
Sebastian, Tim
Beer, Jürg Hans
Mazzolai, Lucia
Aujesky, Drahomir
Hayoz, Daniel
Engelberger, Rolf Peter
Korte, Wolfgang
Kucher, Nils
Barco, Stefano http://orcid.org/0000-0002-2618-347X
Funding for this research was provided by:
University of Zurich
Article History
Received: 23 June 2021
Accepted: 24 October 2021
First Online: 3 November 2021
Declarations
:
: DS is an employee of Sanofi-Aventis (Suisse) SA, Vernier, Switzerland. JHB reports grants from the Swiss National Science Foundation and the Swiss Heart Foundation, grants and personal fees from Boehringer Ingelheim, Pfizer, Bayer, and Daiichi-Sankyo, outside the submitted work. RPE reports personal fees from Bayer, Daiichi-Sankyo and Sanofi-Aventis, outside the submitted work. WK reports personal fees and non-financial support from Bayer, Pfizer, Shire/Takeda, Roche, Daiichi-Sankyo, and Novo Nordisk, outside the submitted work. NK reports personal fees from Bayer, Boston Scientific, Optimed, Bard, and BTG, outside the submitted work. SB reports personal fees from BTG Pharmaceuticals and Leo Pharma, personal fees and non-financial support from Bayer HealthCare, and non-financial support from Daiichi-Sankyo, outside the submitted work.
: The study was approved by local ethics committees of all participating centers and conducted in accordance with the principles of the Declaration of Helsinki.
: Informed consent was waived because data acquisition was completely anonymous without the possibility of tracing back individual patients.